Comparative Pharmacology

Head-to-head clinical analysis: PARACAINE versus PEDIATRIC LTA KIT.

Peer-Reviewed Evidence

Differential Analysis

PARACAINE vs PEDIATRIC LTA KIT

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

PARACAINE

Local Anesthetic

Category C

PEDIATRIC LTA KIT

Local Anesthetic

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Local anesthetic that reversibly blocks sodium channels in neuronal membranes, inhibiting nerve impulse conduction.

PEDIATRIC LTA KIT contains lidocaine, tetracaine, and epinephrine. Lidocaine and tetracaine are amide and ester local anesthetics, respectively, that block voltage-gated sodium channels, preventing nerve impulse propagation. Epinephrine is a sympathomimetic that causes vasoconstriction, prolonging local anesthetic effect and reducing systemic absorption.

Clinical Dosing

10-20 mg orally every 4-6 hours as needed; maximum 80 mg/day.

Not applicable. Pediatric LTA Kit is a topical lidocaine/tetracaine patch for dermal anesthesia. Adult dose: apply one patch to intact skin for 20-30 minutes prior to procedure; remove prior to procedure. Maximum 3 patches per session. Not for systemic use.

Direct Interaction

None Documented

Other Significant Interactions

Clinical Note

moderate

Proparacaine + Fluticasone propionate

"The risk or severity of adverse effects can be increased when Proparacaine is combined with Fluticasone propionate."

Clinical Note

moderate

Proparacaine + Clemastine

"The risk or severity of adverse effects can be increased when Proparacaine is combined with Clemastine."

Clinical Note

moderate

Proparacaine + Venlafaxine

"The risk or severity of adverse effects can be increased when Proparacaine is combined with Venlafaxine."

Clinical Note

moderate